Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wild

Showing results (461-470 of 8,680) with videos related to

Pageof 868
Sort By:
Agents and Actions|April 1, 1990
Problems of mediator measurement for a national advisory service to U.K. anaesthetistsJ Watkins, G Wild
European Journal of Psychotraumatology|October 14, 2011
Self-study assisted cognitive therapy for PTSD: a case studyJennifer Wild, Anke Ehlers
Journal of Medical Ethics|October 15, 2016
Health incentive research and social justice: does the risk of long term harms to systematically disadvantaged groups bear consideration?Verina Wild, Bridget Pratt
Journal of Virology|October 1, 1990
Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challengeE Malvoisin, F Wild
Journal of Evolutionary Biology|September 27, 2015
The association between the emergence of cooperative breeding and clutch sizeC Koykka, G Wild
Pediatric Neurology Briefs|January 14, 2020
<i>STXBP1</i>-Related Developmental and Epileptic EncephalopathyBrittani Wild, Stephen Nelson
The American Journal of Case Reports|August 18, 2017
Spindle Cell Oncocytoma of the Anterior Pituitary Presenting with an Acute Clinical Course Due To Intraventricular Hemorrhage. A Case Report and Review of LiteratureMostafa Osman, Andrew Wild
ESMO Open|August 30, 2017
Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?Nicole Grössmann, Claudia Wild
Carcinogenesis|May 1, 1988
Synthesis of 2-azido-3-methylimidazo[4,5-f]quinoline and photolytic generation of a highly reactive and mutagenic IQ derivativeD Wild, A Dirr
Journal of Market Access & Health Policy|May 10, 2019
Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemptionClaudia Eder, Claudia Wild
Pageof 868

Showing results (461-470 of 8,680) with videos related to

Sort By:
Pageof 868
Agents and Actions|April 1, 1990
Problems of mediator measurement for a national advisory service to U.K. anaesthetistsJ Watkins, G Wild
European Journal of Psychotraumatology|October 14, 2011
Self-study assisted cognitive therapy for PTSD: a case studyJennifer Wild, Anke Ehlers
Journal of Medical Ethics|October 15, 2016
Health incentive research and social justice: does the risk of long term harms to systematically disadvantaged groups bear consideration?Verina Wild, Bridget Pratt
Journal of Virology|October 1, 1990
Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challengeE Malvoisin, F Wild
Journal of Evolutionary Biology|September 27, 2015
The association between the emergence of cooperative breeding and clutch sizeC Koykka, G Wild
Pediatric Neurology Briefs|January 14, 2020
<i>STXBP1</i>-Related Developmental and Epileptic EncephalopathyBrittani Wild, Stephen Nelson
The American Journal of Case Reports|August 18, 2017
Spindle Cell Oncocytoma of the Anterior Pituitary Presenting with an Acute Clinical Course Due To Intraventricular Hemorrhage. A Case Report and Review of LiteratureMostafa Osman, Andrew Wild
ESMO Open|August 30, 2017
Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?Nicole Grössmann, Claudia Wild
Carcinogenesis|May 1, 1988
Synthesis of 2-azido-3-methylimidazo[4,5-f]quinoline and photolytic generation of a highly reactive and mutagenic IQ derivativeD Wild, A Dirr
Journal of Market Access & Health Policy|May 10, 2019
Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemptionClaudia Eder, Claudia Wild
Pageof 868